2m 2m 2m 2m 2m 2m 2m
ProPhase Labs (PRPH)
OTC
$0.18+$0.05 (+34.22%)
Price as of Jan 02, 2026 7:59 PM EST- $1.2MMarket Cap
- -96.47%1-Year Change
- Diagnostics & ResearchIndustry
ProPhase Labs (PRPH)
$0.18+$0.05 (+34.22%)
PRPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.14 | ||
Change | -$0.002 (-1.20%) | ||
Open | $0.13 | ||
High | $0.15 | ||
Low | $0.13 | ||
Previous Close | $0.14 | ||
Volume | 68,986 | ||
30-Day Average Volume | 40,892 | ||
1-Week Change | 35.60% | ||
1-Month Change | 0.44% | ||
1-Year Change | -96.47% | ||
3-Year Change | -99.84% | ||
5-Year Change | -99.70% | ||
Fundamentals | |||
Shares Outstanding | 4.2M | ||
Total Assets | $65.7M | ||
Market Cap | $1.2M | ||
Enterprise Value | $4.5M | ||
Period: QTR TTM FY | |||
Revenue | $883,000.00 | ||
Net Income | -$6.8M | ||
Free Cash Flow | -$3.5M | ||
EBIT | -$7.0M | ||
EBITDA | -$6.0M | ||
Net Working Capital | -$47.5M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 0 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 05/24/2022 | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/22/2025 | ||
Annual Dividend Yield